Capha Pharmaceuticals Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was CAD 0.020184 million compared to CAD 0.020879 million a year ago.
For the nine months, net loss was CAD 0.052407 million compared to CAD 0.058133 million a year ago.